Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment
Abstract Background Gold nanoparticles (AuNP) are effective radiosensitisers, however, successful clinical translation has been impeded by short systemic circulation times and poor internalisation efficiency. This work examines the potential of RALA, a short amphipathic peptide, to enhance the uptak...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-021-01019-8 |
id |
doaj-7e5641acdb7d44ffa88ca6b2e0d590dd |
---|---|
record_format |
Article |
spelling |
doaj-7e5641acdb7d44ffa88ca6b2e0d590dd2021-09-26T11:38:32ZengBMCJournal of Nanobiotechnology1477-31552021-09-0119111310.1186/s12951-021-01019-8Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatmentLindsey A. Bennie0Jie Feng1Christopher Emmerson2Wendy B. Hyland3Kyle B. Matchett4Helen O. McCarthy5Jonathan A. Coulter6School of Pharmacy, Queen’s University BelfastSchool of Pharmacy, Queen’s University BelfastSchool of Pharmacy, Queen’s University BelfastWestern Health & Social Care Trust, North West Cancer Centre, Altnagelvin HospitalNorthern Ireland Centre for Stratified Medicine, C-TRIC, Altnagelvin Hospital CampusSchool of Pharmacy, Queen’s University BelfastSchool of Pharmacy, Queen’s University BelfastAbstract Background Gold nanoparticles (AuNP) are effective radiosensitisers, however, successful clinical translation has been impeded by short systemic circulation times and poor internalisation efficiency. This work examines the potential of RALA, a short amphipathic peptide, to enhance the uptake efficiency of negatively charged AuNPs in tumour cells, detailing the subsequent impact of AuNP internalisation on tumour cell radiation sensitivity. Results RALA/Au nanoparticles were formed by optimising the ratio of RALA to citrate capped AuNPs, with assembly occurring through electrostatic interactions. Physical nanoparticle characteristics were determined by UV–vis spectroscopy and dynamic light scattering. Nano-complexes successfully formed at w:w ratios > 20:1 (20 µg RALA:1 µg AuNP) yielding positively charged nanoparticles, sized < 110 nm with PDI values < 0.52. ICP-MS demonstrated that RALA enhanced AuNP internalisation by more than threefold in both PC-3 and DU145 prostate cancer cell models, without causing significant toxicity. Importantly, all RALA-AuNP formulations significantly increased prostate cancer cell radiosensitivity. This effect was greatest using the 25:1 RALA-AuNP formulation, producing a dose enhancement effect (DEF) of 1.54 in PC3 cells. Using clinical radiation energies (6 MV) RALA-AuNP also significantly augmented radiation sensitivity. Mechanistic studies support RALA-AuNP nuclear accumulation resulting in increased DNA damage yields. Conclusions This is the first study to demonstrate meaningful radiosensitisation using low microgram AuNP treatment concentrations. This effect was achieved using RALA, providing functional evidence to support our previous imaging study indicating RALA-AuNP nuclear accumulation. Graphic abstracthttps://doi.org/10.1186/s12951-021-01019-8Gold nanoparticlesRALARadiosensitisationProstate cancerNanomedicine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lindsey A. Bennie Jie Feng Christopher Emmerson Wendy B. Hyland Kyle B. Matchett Helen O. McCarthy Jonathan A. Coulter |
spellingShingle |
Lindsey A. Bennie Jie Feng Christopher Emmerson Wendy B. Hyland Kyle B. Matchett Helen O. McCarthy Jonathan A. Coulter Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment Journal of Nanobiotechnology Gold nanoparticles RALA Radiosensitisation Prostate cancer Nanomedicine |
author_facet |
Lindsey A. Bennie Jie Feng Christopher Emmerson Wendy B. Hyland Kyle B. Matchett Helen O. McCarthy Jonathan A. Coulter |
author_sort |
Lindsey A. Bennie |
title |
Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment |
title_short |
Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment |
title_full |
Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment |
title_fullStr |
Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment |
title_full_unstemmed |
Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment |
title_sort |
formulating rala/au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment |
publisher |
BMC |
series |
Journal of Nanobiotechnology |
issn |
1477-3155 |
publishDate |
2021-09-01 |
description |
Abstract Background Gold nanoparticles (AuNP) are effective radiosensitisers, however, successful clinical translation has been impeded by short systemic circulation times and poor internalisation efficiency. This work examines the potential of RALA, a short amphipathic peptide, to enhance the uptake efficiency of negatively charged AuNPs in tumour cells, detailing the subsequent impact of AuNP internalisation on tumour cell radiation sensitivity. Results RALA/Au nanoparticles were formed by optimising the ratio of RALA to citrate capped AuNPs, with assembly occurring through electrostatic interactions. Physical nanoparticle characteristics were determined by UV–vis spectroscopy and dynamic light scattering. Nano-complexes successfully formed at w:w ratios > 20:1 (20 µg RALA:1 µg AuNP) yielding positively charged nanoparticles, sized < 110 nm with PDI values < 0.52. ICP-MS demonstrated that RALA enhanced AuNP internalisation by more than threefold in both PC-3 and DU145 prostate cancer cell models, without causing significant toxicity. Importantly, all RALA-AuNP formulations significantly increased prostate cancer cell radiosensitivity. This effect was greatest using the 25:1 RALA-AuNP formulation, producing a dose enhancement effect (DEF) of 1.54 in PC3 cells. Using clinical radiation energies (6 MV) RALA-AuNP also significantly augmented radiation sensitivity. Mechanistic studies support RALA-AuNP nuclear accumulation resulting in increased DNA damage yields. Conclusions This is the first study to demonstrate meaningful radiosensitisation using low microgram AuNP treatment concentrations. This effect was achieved using RALA, providing functional evidence to support our previous imaging study indicating RALA-AuNP nuclear accumulation. Graphic abstract |
topic |
Gold nanoparticles RALA Radiosensitisation Prostate cancer Nanomedicine |
url |
https://doi.org/10.1186/s12951-021-01019-8 |
work_keys_str_mv |
AT lindseyabennie formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment AT jiefeng formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment AT christopheremmerson formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment AT wendybhyland formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment AT kylebmatchett formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment AT helenomccarthy formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment AT jonathanacoulter formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment |
_version_ |
1716867839034392576 |